Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Pharmacotherapy|June 30, 2009
Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literatureShannon R Christiansen, Alberto Broniscer, J Carl Panetta, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 3, 2020
LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumorsBo Zhong, Olivia Campagne, Ralph Salloum, et al.
Journal of Clinical Pharmacology|November 9, 2023
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer AgentsWilliam C Zamboni, Rosane Charlab, Gilbert J Burckart, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 15, 2002
New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065Feng Bai, Mark N Kirstein, Suzan K Hanna, et al.
Journal of Statistical Theory and Practice|May 21, 2013
Effect on Prediction when Modeling Covariates in Bayesian Nonparametric ModelsAlejandro Cruz-Marcelo, Gary L Rosner, Peter Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Using pharmacokinetic and pharmacodynamic modeling and simulation to evaluate importance of schedule in topotecan therapy for pediatric neuroblastomaJohn C Panetta, Paula Schaiquevich, Victor M Santana, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 10, 2014
Determination of crizotinib in human and mouse plasma by liquid chromatography electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)Michael S Roberts, David C Turner, Alberto Broniscer, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2021
Development and validation of an LC-MS/MS method to quantify the bromodomain and extra-terminal (BET) inhibitor JQ1 in mouse plasma and brain microdialysate: Application to cerebral microdialysis studySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Clinical and Translational Science|June 1, 2021
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation studyJohn C Panetta, Olivia Campagne, Jessica Gartrell, et al.
Molecules (Basel, Switzerland)|September 9, 2022
Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis StudySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Pharmacotherapy|June 30, 2009
Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literatureShannon R Christiansen, Alberto Broniscer, J Carl Panetta, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 3, 2020
LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumorsBo Zhong, Olivia Campagne, Ralph Salloum, et al.
Journal of Clinical Pharmacology|November 9, 2023
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer AgentsWilliam C Zamboni, Rosane Charlab, Gilbert J Burckart, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 15, 2002
New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065Feng Bai, Mark N Kirstein, Suzan K Hanna, et al.
Journal of Statistical Theory and Practice|May 21, 2013
Effect on Prediction when Modeling Covariates in Bayesian Nonparametric ModelsAlejandro Cruz-Marcelo, Gary L Rosner, Peter Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Using pharmacokinetic and pharmacodynamic modeling and simulation to evaluate importance of schedule in topotecan therapy for pediatric neuroblastomaJohn C Panetta, Paula Schaiquevich, Victor M Santana, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 10, 2014
Determination of crizotinib in human and mouse plasma by liquid chromatography electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)Michael S Roberts, David C Turner, Alberto Broniscer, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2021
Development and validation of an LC-MS/MS method to quantify the bromodomain and extra-terminal (BET) inhibitor JQ1 in mouse plasma and brain microdialysate: Application to cerebral microdialysis studySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Clinical and Translational Science|June 1, 2021
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation studyJohn C Panetta, Olivia Campagne, Jessica Gartrell, et al.
Molecules (Basel, Switzerland)|September 9, 2022
Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis StudySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Pageof 22